0.00Open0.28Pre Close0 Volume3 Open Interest21.50Strike Price0.00Turnover154.24%IV19.57%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.28Extrinsic Value100Contract SizeAmericanOptions Type0.1841Delta0.0886Gamma65.06Leverage Ratio-0.0966Theta0.0003Rho11.98Eff Leverage0.0052Vega
Summit Therapeutics Stock Discussion
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet